CGH
CNMD icon

Crossmark Global Holdings’s CONMED CNMD Stock Holding History

Crossmark Global Holdings’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,352
Closed -$258K – 1332
2023
Q4 		$258K Sell
2,352
-229
-9% -$23.7K 0.01% 1143
2023
Q3 		$262K Sell
2,581
-14
-0.5% -$1.61K 0.01% 1078
2023
Q2 		$308K Sell
2,595
-459
-15% -$56K 0.01% 1058
2023
Q1 		$317K Buy
3,054
+490
+19% +$47.4K 0.01% 1021
2022
Q4 		$227K Sell
2,564
-186
-7% -$15.4K 0.01% 1132
2022
Q3 		$221K Buy
2,750
+10
+0.4% +$943 0.01% 1130
2022
Q2 		$263K Sell
2,740
-60
-2% -$7.2K 0.01% 1092
2022
Q1 		$416K Buy
2,800
+80
+3% +$11.2K 0.01% 988
2021
Q4 		$386K Buy
2,720
+220
+9% +$31.2K 0.01% 1022
2021
Q3 		$327K Sell
2,500
-80
-3% -$10.5K 0.01% 1125
2021
Q2 		$355K Sell
2,580
-100
-4% -$13.7K 0.01% 1096
2021
Q1 		$350K Sell
2,680
-110
-4% -$13.2K 0.01% 1094
2020
Q4 		$312K Sell
2,790
-1,370
-33% -$130K 0.01% 1065
2020
Q3 		$327K Sell
4,160
-220
-5% -$17.9K 0.01% 969
2020
Q2 		$315K Buy
4,380
+340
+8% +$23.7K 0.01% 976
2020
Q1 		$231K Sell
4,040
-40
-1% -$3.69K 0.01% 984
2019
Q4 		$456K Sell
4,080
-2,500
-38% -$266K 0.01% 848
2019
Q3 		$633K Sell
6,580
-160
-2% -$15K 0.02% 696
2019
Q2 		$577K Sell
6,740
-536
-7% -$44.1K 0.02% 755
2019
Q1 		$605K Buy
7,276
+270
+4% +$19.6K 0.02% 728
2018
Q4 		$450K Buy
7,006
+2,480
+55% +$170K 0.01% 808
2018
Q3 		$359K Buy
4,526
+190
+4% +$14.7K 0.01% 1190
2018
Q2 		$317K Buy
4,336
+100
+2% +$6.8K 0.01% 1264
2018
Q1 		$268K Sell
4,236
-1,016
-19% -$60.7K 0.01% 1345
2017
Q4 		$268K Sell
5,252
-104
-2% -$5.42K 0.01% 1434
2017
Q3 		$281K Buy
+5,356
New +$269K 0.01% 1360
2016
Q3 		$281K Buy
+5,356
New +$227K 0.01% 1360

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Crossmark Global Holdings's CNMD Position: Q1 2024 in Review

Crossmark Global Holdings sold out of CONMED (CNMD) in Q1 2024, closing a stake of 2,352 shares — an estimated $258K sold.

Crossmark Global Holdings first reported a position in CNMD in Q3 2016 and held it in 27 quarters. The position peaked at $633K in Q3 2019. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • Crossmark Global Holdings reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • Crossmark Global Holdings sold 2,352 CONMED shares in Q1 2024, an estimated $258K.
  • Crossmark Global Holdings first reported a position in CONMED in Q3 2016 and held it in 27 quarters.
  • Crossmark Global Holdings's CONMED position peaked at $633K in Q3 2019.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on Crossmark Global Holdings's 13F filing for Q1 2024, filed 13 May 2024.